Biodegradable Polymer Biolimus-Eluting Stent Versus Durable Polymer Everolimus-Eluting Stent
Masahiro NatsuakiKen KozumaTakeshi MorimotoKazushige KadotaToshiya MuramatsuYoshihisa NakagawaTakashi AkasakaKeiichi IgarashiKengo TanabeYoshihiro MorinoTetsuya IshikawaHideo NishikawaMasaki AwataMitsuru AbeHisayuki OkadaYoshiki TakatsuNobuhiko OgataKazuo KimuraKazushi UrasawaYasuhiro TarutaniNobuo ShiodeTakeshi Kimura
Abstract
One-year clinical and angiographic outcome after BES implantation was noninferior to and not different from that after EES implantation in a mostly stable coronary artery disease population. One-year clinical outcome after both BES and EES use was excellent, with a low rate of TLR and extremely low rate of stent thrombosis.
Metrics
Citation History
Topics
Related Documents
Biodegradable polymer biolimus-eluting stent versus durable polymer everolimus-eluting stent in patients with acute myocardial infarction
Hyun‐Jong LeeTaek Kyu ParkYoung Bin SongYoung Jin ChoiCheol Woong YuJeong Hoon YangJoo‐Yong HahnSeung‐Hyuk ChoiRak Kyeong ChoiJin-Ho ChoiJin-Sik ParkJe Sang KimTae‐Hoon KimHo Joon JangSang Hoon LeeWon Heum ShimYoung Moo RohHyeon‐Cheol Gwon
Abluminal biodegradable polymer biolimus-eluting versus durable polymer everolimus-eluting stent in patients with diabetes mellitus
Valeria ParadiesGeorgios J. VlachojannisKees‐Jan RoyaardsJochem WassingMartin van der EntPieter C. Smits
SEVEN YEAR CLINICAL OUTCOMES OF BIODEGRADABLE POLYMER BIOLIMUS ELUTING STENT VERSUS DURABLE POLYMER EVEROLIMUS ELUTING STENT IN DIABETIC PATIENTS
Abluminal biodegradable polymer biolimus-eluting stent versus durable polymer everolimus-eluting stent (COMPARE II): a randomised, controlled, non-inferiority trial
Pieter C. SmitsSjoerd H. HofmaMario TogniNicolás VazquezMariano ValdésVassilis VoudrisTon SlagboomJean-Jaques GoyA.G. VuillomenetAntoni SerraRamiro TrilloPeter den HeijerMartin van der Ent
Biolimus-eluting versus everolimus-eluting stents in coronary artery disease: a pooled analysis from the NEXT (NOBORI biolimus-eluting versus XIENCE/PROMUS everolimus-eluting stent) and COMPARE II (Abluminal biodegradable polymer biolimus-eluting stent versus durable polymer everolimus-eluting stent) randomised trials
Georgios J. VlachojannisSerban PuricelMasahiro NatsuakiTakeshi MorimotoPieter C. SmitsTakeshi Kimura